David Ames

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. ncbi request reprint For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
    David Ames
    Department of Psychiatry, University of Melbourne, Australia
    Int Psychogeriatr 20:259-92. 2008
  2. ncbi request reprint For debate: is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive?
    David Ames
    University of Melbourne, Australia
    Int Psychogeriatr 19:1003. 2007
  3. doi request reprint Aβ amyloid, cognition, and APOE genotype in healthy older adults
    Yen Ying Lim
    Department of Psychiatry, University of Melbourne, Parkville, Australia
    Alzheimers Dement 9:538-45. 2013
  4. doi request reprint Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
    Yen Ying Lim
    Department of Psychiatry, University of Melbourne, Parkville, Vic, Australia
    J Clin Exp Neuropsychol 34:345-58. 2012
  5. doi request reprint Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults
    Rachel F Buckley
    Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia
    Int Psychogeriatr 26:1737-46. 2014
  6. doi request reprint Attitudes to aging in older carers - do they have a role in their well-being?
    Samantha M Loi
    Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, Normanby House, St George s Hospital, 283 Cotham Road, Kew, Victoria 3101, Australia
    Int Psychogeriatr 27:1893-901. 2015
  7. pmc Incidence of cerebral microbleeds in preclinical Alzheimer disease
    Paul A Yates
    From the Department of Nuclear Medicine and Centre for PET P A Y, V L V, C C R, Austin Health, Heidelberg The University of Melbourne P A Y, P M D, C S, C C R, Parkville Department of Radiology P M D, P M P, C S, Royal Melbourne Hospital, Parkville National Ageing Research Institute D A, Parkville CSIRO Preventative Health Flagship O S, Parkville Florey Institute of Neuroscience and Mental Health K A E, C L M, V L V, The University of Melbourne, Parkville Academic Unit for Psychiatry of Old Age K A E, D A, Department of Psychiatry, The University of Melbourne, Kew, Victoria Centre of Excellence for Alzheimer s Disease Research and Care R N M, School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Australia
    Neurology 82:1266-73. 2014
  8. doi request reprint Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative
    Kathryn A Ellis
    Department of Psychiatry, Academic Unit for Psychiatry of Old Age, University of Melbourne, Kew, Victoria, Australia
    Alzheimers Dement 6:291-6. 2010
  9. doi request reprint Factors associated with depression in older carers
    Samantha M Loi
    Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Kew, Victoria, Australia
    Int J Geriatr Psychiatry 31:294-301. 2016
  10. doi request reprint Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
    Kathryn A Ellis
    Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne St Vincent s Aged Psychiatry Service, St George s Hospital, Kew, Victoria, Australia
    Int Psychogeriatr 26:543-54. 2014

Detail Information

Publications45

  1. ncbi request reprint For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
    David Ames
    Department of Psychiatry, University of Melbourne, Australia
    Int Psychogeriatr 20:259-92. 2008
  2. ncbi request reprint For debate: is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive?
    David Ames
    University of Melbourne, Australia
    Int Psychogeriatr 19:1003. 2007
  3. doi request reprint Aβ amyloid, cognition, and APOE genotype in healthy older adults
    Yen Ying Lim
    Department of Psychiatry, University of Melbourne, Parkville, Australia
    Alzheimers Dement 9:538-45. 2013
    ..Further, when demographic variables were controlled, the influence of APOE ε4 on the relationship between cerebral Aβ and cognition dissipated...
  4. doi request reprint Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
    Yen Ying Lim
    Department of Psychiatry, University of Melbourne, Parkville, Vic, Australia
    J Clin Exp Neuropsychol 34:345-58. 2012
    ..These results suggest that the CogState Brief Battery can be used to screen for AD-related cognitive changes...
  5. doi request reprint Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults
    Rachel F Buckley
    Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia
    Int Psychogeriatr 26:1737-46. 2014
    ..Autobiographical memory (ABM), personal semantic memory (PSM), and autonoetic consciousness are affected in individuals with mild cognitive impairment (MCI) but their relationship with Alzheimer's disease (AD) biomarkers are unclear...
  6. doi request reprint Attitudes to aging in older carers - do they have a role in their well-being?
    Samantha M Loi
    Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, Normanby House, St George s Hospital, 283 Cotham Road, Kew, Victoria 3101, Australia
    Int Psychogeriatr 27:1893-901. 2015
    ..This is one of the first studies to report on older carers, their attitudes to aging, and the relationship with carer-related factors...
  7. pmc Incidence of cerebral microbleeds in preclinical Alzheimer disease
    Paul A Yates
    From the Department of Nuclear Medicine and Centre for PET P A Y, V L V, C C R, Austin Health, Heidelberg The University of Melbourne P A Y, P M D, C S, C C R, Parkville Department of Radiology P M D, P M P, C S, Royal Melbourne Hospital, Parkville National Ageing Research Institute D A, Parkville CSIRO Preventative Health Flagship O S, Parkville Florey Institute of Neuroscience and Mental Health K A E, C L M, V L V, The University of Melbourne, Parkville Academic Unit for Psychiatry of Old Age K A E, D A, Department of Psychiatry, The University of Melbourne, Kew, Victoria Centre of Excellence for Alzheimer s Disease Research and Care R N M, School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Australia
    Neurology 82:1266-73. 2014
    ..We sought to determine the incidence and associations of lobar microbleeds (LMBs) in a longitudinal cohort with (11)C-Pittsburgh compound B (PiB) PET imaging...
  8. doi request reprint Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative
    Kathryn A Ellis
    Department of Psychiatry, Academic Unit for Psychiatry of Old Age, University of Melbourne, Kew, Victoria, Australia
    Alzheimers Dement 6:291-6. 2010
    ..Cross-sectional analysis of baseline data is revealing links between cognition, brain amyloid burden, structural brain changes, biomarkers, and lifestyle...
  9. doi request reprint Factors associated with depression in older carers
    Samantha M Loi
    Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Kew, Victoria, Australia
    Int J Geriatr Psychiatry 31:294-301. 2016
    ..With the increasing ageing population and reliance on informal carers, this study aims to identify factors associated with depression in carers in the older age group, using factors that have not been previously investigated...
  10. doi request reprint Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
    Kathryn A Ellis
    Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne St Vincent s Aged Psychiatry Service, St George s Hospital, Kew, Victoria, Australia
    Int Psychogeriatr 26:543-54. 2014
    ..The first aim was to compute rates of transition from HC to MCI, and MCI to AD. The second aim was to characterize the cognitive profiles of individuals who transitioned to a more severe disease stage compared with those who did not...
  11. doi request reprint Short term stability of verbal memory impairment in mild cognitive impairment and Alzheimer's disease measured using the International Shopping List Test
    Yen Ying Lim
    Department of Psychiatry, University of Melbourne, Parkville, Australia
    J Clin Exp Neuropsychol 34:853-63. 2012
    ..There was no difference between groups on within-subject variability. These data suggest that in English-speaking samples, the ISLT is sensitive to MCI and can be given repeatedly in order to assess change in memory...
  12. ncbi request reprint Advances in structural and molecular neuroimaging in Alzheimer's disease
    Kathryn A Ellis
    Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, Melbourne, Vic, Australia
    Med J Aust 194:S20-3. 2011
    ....
  13. doi request reprint Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study
    Robert H Pietrzak
    Robert H Pietrzak, PhD, MPH, J Cobb Scott, PhD, United States Department of Veterans Affairs National Center for Posttraumatic Stress Disorder, Clinical Neurosciences Division, VA Connecticut Healthcare System, West Haven and Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA Alexander Neumeister, MD, Departments of Psychiatry and Radiology, New York University School of Medicine, New York, USA Yen Ying Lim, PhD, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia David Ames, MD, Academic Unit for Psychiatry of Old Age, St Vincent s Health, Department of Psychiatry, The University of Melbourne, Kew and National Ageing Research Institute, Parkville, Victoria, Australia Kathryn A Ellis, PhD, The Florey Institute of Neuroscience and Mental Health, Parkville, Academic Unit for Psychiatry of Old Age, St Vincent s Health, Department of Psychiatry, The University of Melbourne, Kew and National Ageing Research Institute, Parkville, Victoria, Pest Infestation Laboratory
    Br J Psychiatry 204:400-1. 2014
    ..These findings suggest that interventions to mitigate anxiety symptoms may help delay memory decline in otherwise healthy older adults with elevated beta-amyloid. ..
  14. doi request reprint Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing
    Rachel F Buckley
    Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Vic, Australia The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Vic, Australia
    J Alzheimers Dis 40:551-61. 2014
    ..Mild cognitive impairment (MCI) is routinely diagnosed with the aid of neuropsychological tests, which do not tap the ABM and PSM domains...
  15. ncbi request reprint The prevalence of anxiety in older adults: methodological issues and a review of the literature
    Christina Bryant
    School of Behavioural Science, University of Melbourne, Victoria, Australia
    J Affect Disord 109:233-50. 2008
    ..This review provides a comprehensive overview of this literature and discusses some unresolved controversies in the field...
  16. doi request reprint Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction
    Lisbeth Evered
    From the Centre for Anaesthesia and Cognitive Function, Department of Anaesthesia and Acute Pain Medicine, St Vincent s Hospital, and Anaesthesia, Perioperative, and Pain Medicine Unit, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia L E, B S, D A S Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, and National Ageing Research Institute, Parkville, Victoria, Australia D A Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia P M and Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at University of Gothenburg, Molndal, Gothenburg, Sweden K B
    Anesthesiology 124:353-61. 2016
    ..The exact cause of POCD remains unknown. The authors hypothesized that elderly individuals with Alzheimer disease (AD) neuropathology, identified by cerebrospinal fluid (CSF) analysis, would have increased the risk for POCD...
  17. doi request reprint The Women's Healthy Ageing Project: fertile ground for investigation of healthy participants 'at risk' for dementia
    Cassandra E I Szoeke
    Department of Medicine, University of Melbourne, Parkville, Victoria, Australia
    Int Rev Psychiatry 25:726-37. 2013
    ....
  18. doi request reprint The role of physical and psychological variables in predicting the outcome of hospitalization in very old adults
    Christina Bryant
    Psychological Sciences, University of Melbourne, VIC 3010, Australia
    Arch Gerontol Geriatr 53:146-51. 2011
    ..The findings also highlight some difficulties in the use of psychological measures in old-old populations, and the need for more research that recognizes the oldest old as a distinct group...
  19. ncbi request reprint A memory clinic at a geriatric hospital: a report on 577 patients assessed with the CAMDEX over 9 years
    Joe A Stratford
    Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia
    Aust N Z J Psychiatry 37:319-26. 2003
    ....
  20. doi request reprint Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts
    Eileen M Moore
    Department of Psychiatry, The University of Melbourne, Parkville, Vic, Australia Barwon Health, Geelong, Vic, Australia
    J Alzheimers Dis 39:661-8. 2014
    ..Given the prevalence of low vitamin B12 levels among the elderly, and the global deployment of food fortification programs, investigation of the associations between cognitive impairment, vitamin B12, and folate are needed...
  21. doi request reprint Dehydroepiandrosterone sulfate and cognition in midlife, post-menopausal women
    Charlene K Z Chua
    Department of Medicine, University of Melbourne, Parkville, Victoria, Australia
    Neurobiol Aging 35:1654-5. 2014
    ..These findings fail to support the view that DHEAS is substantially related to cognitive function in midlife, post-menopausal women...
  22. doi request reprint Cognitive impairment and vitamin B12: a review
    Eileen Moore
    Department of Psychiatry, The University of Melbourne, Department of Surgery, The Geelong Hospital, Barwon Health, Geelong, Victoria, Australia
    Int Psychogeriatr 24:541-56. 2012
    ..In addition, we reviewed the evidence as to whether vitamin B12 therapy is efficacious for cognitive impairment and dementia...
  23. doi request reprint The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
    Kathryn A Ellis
    Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, St Vincent s Aged Psychiatry Service, St George s Hospital, Victoria, Australia
    Int Psychogeriatr 21:672-87. 2009
    ..This paper describes the recruitment of the cohort and gives information about the study methodology, baseline demography, diagnoses, medical comorbidities, medication use, and cognitive function of the participants...
  24. doi request reprint Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment
    Rachel Buckley
    Melbourne School of Psychological Sciences, University of Melbourne, Parkville, Vic, Australia Florey Institutes of Neuroscience and Mental Health, Melbourne, Vic, Australia
    Age Ageing 44:1012-9. 2015
    ..The aim was to examine patterns of relationships between self and informant reports from a phenomenological perspective...
  25. doi request reprint The adverse mental health of carers: Does the patient diagnosis play a role?
    Samantha M Loi
    Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, Normanby House, St George s Hospital, 283 Cotham Road, Kew, Victoria 3101, Australia National Ageing Research Institute, 34 54 Poplar Road, Parkville, Victoria 3052, Australia Melbourne Neuropsychiatry Unit, Melbourne Health, The Royal Melbourne Hospital, 300 Grattan Street, Parkville 3050, Australia Electronic address
    Maturitas 82:134-8. 2015
    ..Less is known about the mental health of carers of people with other conditions. This study compared depression and burden in older carers looking after people with a variety of conditions...
  26. doi request reprint Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joint replacement surgery
    Brendan Silbert
    From the Centre for Anaesthesia and Cognitive Function, Department of Anaesthesia, St Vincent s Hospital, Melbourne, Victoria, Australia B S, L E, D A S Anaesthesia, Perioperative and Pain Medicine Unit, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia B S, L E, D A S, Department of Surgery, Monash University, Melbourne, Victoria, Australia S M Malabar Orthopaedic Clinic, Windsor, Victoria, Australia S M Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia P C Department of Orthopaedics, St Vincent s Hospital, Melbourne, Victoria, Australia P C Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia D A National Aging Research Institute, Parkville, Victoria, Australia D A Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia P M and School of Population Health, University of Adelaide, Adelaide, South Australia, Zoology Department
    Anesthesiology 122:1224-34. 2015
    ..Additionally, the incidence of cognitive decline at 12 months after surgery was identified...
  27. doi request reprint Negative argument for debate with V. O. Emery for J Neural Transmission : Alzheimer's disease: are we intervening too late? No we are not. Con
    David Ames
    National Ageing Research Institute, Royal Melbourne Hospital, University of Melbourne, PO Box 2127, Parkville, Vic, 3050, Australia
    J Neural Transm (Vienna) 118:1379-81. 2011
    ..Treatment of established AD with cholinesterase inhibitors and memantine, coupled with referral of interested patients to evaluative drug trials, is the best we can do at present...
  28. doi request reprint Depression and anxiety in medically unwell older adults: prevalence and short-term course
    Christina Bryant
    School of Behavioural Science, University of Melbourne, Victoria, Australia
    Int Psychogeriatr 21:754-63. 2009
    ..The objective of this study was to examine the prevalence and short-term course of depression and anxiety in a sample of hospitalized, medically unwell older adults, using both a symptom measure and a diagnostic instrument...
  29. ncbi request reprint Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease
    Craig W Ritchie
    Department of Psychiatry and Behavioural Science, Royal Free and University College Medical School, University College London, Royal Free Campus, Rowland Hill Street, London, UK NW3 2PF
    Am J Geriatr Psychiatry 12:358-69. 2004
    ..However, both galantamine and rivastigmine were associated with a greater risk of trial dropout than placebo, especially at higher dosing levels...
  30. doi request reprint The episodic buffer and learning in early Alzheimer's disease
    Carmela Germano
    La Trobe University, Melbourne, Victoria, Australia
    J Clin Exp Neuropsychol 30:627-38. 2008
    ..The overall pattern of results indicates a staging of working-memory impairment in early Alzheimer's disease...
  31. ncbi request reprint Is late onset depression a prodrome to dementia?
    Isaac Schweitzer
    Department of Psychiatry, University of Melbourne, Australia
    Int J Geriatr Psychiatry 17:997-1005. 2002
    ..Recent research suggests there are clinical and biological differences between late onset depression (LOD) and early-onset depression (EOD)...
  32. ncbi request reprint Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease
    Serge Gauthier
    Alzheimer s Disease Research Unit, McGill Centre for Studies in Aging, Verdun, Quebec, Canada
    Int Psychogeriatr 14:389-404. 2002
    ..This subanalysis of a large, double-blind, placebo-controlled trial examined the prevalence of behavioral symptoms in moderate to severe Alzheimer's disease (AD), and the effect of treatment with donepezil...
  33. ncbi request reprint Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit
    Dianne Kirby
    Alfred Hospital, Victoria, Australia
    Int J Geriatr Psychiatry 17:231-7. 2002
    ..Design and setting Retrospective controlled analysis in a 36-bed inpatient unit for elderly psychiatric patients in Melbourne...
  34. ncbi request reprint A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia
    Henry Brodaty
    Academic Department for Old Age Psychiatry, School of Psychiatry, University of New South Wales, Sydney, Australia
    J Clin Psychiatry 64:134-43. 2003
    ..This randomized, double-blind, placebo-controlled trial examined the efficacy and safety of risperidone in the treatment of aggression, agitation, and psychosis in elderly nursing-home patients with dementia...
  35. doi request reprint Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
    Lars Lannfelt
    Department of Public Health and Geriatrics, Uppsala University Hospital, Uppsala, Sweden
    Lancet Neurol 7:779-86. 2008
    ..Strong preclinical efficacy data and the completion of early, clinical safety studies have preceded this phase IIa study, the aim of which was to assess the effects of PBT2 on safety, efficacy, and biomarkers of AD...
  36. ncbi request reprint Use of antidepressant medications in the general practice setting. A critical review
    Kelsey Hegarty
    Department of General Practice, University of Melbourne, Victoria
    Aust Fam Physician 32:229-34, 236-7, 239 passim. 2003
    ..Antidepressants are commonly prescribed in general practice for depression, but also for a wide range of other psychiatric conditions and physical problems...
  37. ncbi request reprint The combination of cognitive testing and an informant questionnaire in screening for dementia
    Richard Knafelc
    Bundoora Extended Care Centre, Bundoora, Victoria, Australia
    Age Ageing 32:541-7. 2003
    ..Aim: A cognitive test and an informant report questionnaire were used together to investigate whether their combined use could improve the accuracy of detecting dementia in a memory clinic, compared with either test used alone...
  38. ncbi request reprint Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial
    Craig W Ritchie
    Departments of Pathology, The University of Melbourne, The Mental Health Research Institute of Victoria, Parkville, Victoria, Australia
    Arch Neurol 60:1685-91. 2003
    ..Alzheimer disease (AD) may be caused by the toxic accumulation of beta-amyloid (Abeta)...
  39. ncbi request reprint International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia
    Cornelius Katona
    Old Age Taskforce, World Federation of Societies of Biological Psychiatry, Kent Institute of Medicine and Health Sciences, University of Kent, Canterbury, UK
    Int Psychogeriatr 19:345-54. 2007
    ..The growth in the older population across the world, and their potential for increasing political empowerment may lead to a radical re-evaluation of the economics of treatment in dementia...
  40. ncbi request reprint Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial
    Henry Brodaty
    Academic Department of Psychogeriatrics, School of Psychiatry, University of New South Wales, Sydney, Australia
    Int J Geriatr Psychiatry 20:1153-7. 2005
    ....
  41. ncbi request reprint The 2005 International Psychogeriatric Association (IPA) research awards in psychogeriatrics
    David Ames
    Int Psychogeriatr 18:1-2. 2006
  42. ncbi request reprint Duration of risperidone treatment for BPSD
    John Snowdon
    Int J Geriatr Psychiatry 21:699-701. 2006
  43. ncbi request reprint Has the management of Alzheimer's disease changed over the past 100 years?
    Konrad Maurer
    Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt on Main, Frankfurt, Germany
    Lancet 368:1619-21. 2006
  44. ncbi request reprint Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
    David Ames
    Int Psychogeriatr 19:1-8. 2007
  45. ncbi request reprint Metabolic and endocrinological causes of dementia
    Leon Flicker
    School of Medicine and Pharmacology, University of Western Australia, Royal Perth Hospital, Box X2213 GPO, Perth, WA 6001, Australia
    Int Psychogeriatr 17:S79-92. 2005
    ..The existence of these conditions provides some justification for routine investigations commonly performed on patients presenting with possible early dementia...